肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

JC多瘤病毒与前列腺癌——是敌是友?

JC Polyomavirus in Prostate Cancer—Friend or Foe?

原文发布日期:21 May 2025

DOI: 10.3390/cancers17101725

类型: Article

开放获取: 是

 

英文摘要:

Background/Objectives: Recently, many researchers have evaluated various viruses, including polyomaviruses (JCV, BKV) and EBV, as potential factors playing a role in the development and/or progression of prostate cancer (PCa), one of the most common cancers in men. Therefore, we aimed to assess the frequency of the JCPyV DNA in tissue collected from PCa patients.Methods: We detected the presence of viral DNA (PCR) in 49.6% of clinical samples, including 71.9% with single EBV infection and 28.1% with EBV/JCV co-infection. We did not detect BKV or a single JCV infection. Therefore, we compared patients with EBV mono-infection with EBV/JCV co-infected patients in the context of risk group, Gleason score, and TNM classification.Results: Our results showed differences in clinicopathological features between single EBV infection and EBV/JCV co-infection. In the group of patients with single EBV infection, most patients were classified as medium/high risk, while in the group with EBV/JCV co-infection, most patients were classified as low risk.Conclusions: Among patients with single EBV infection, a more advanced stage of cancer was observed than in EBV/JCV co-infection. Moreover, the level of anti-EBVCA and anti-EBNA antibodies as well as EBV load was higher in the case of single infection compared to EBV/JCV co-infection. Higher antibody levels were detected in more advanced tumor stages in single EBV infection. Does JCV only “reside” in prostate cells or is it a co-factor in EBV infection? In light of these studies, there is a need to clarify the role of JCV virus in the development and/or progression of prostate cancer.

 

摘要翻译: 

背景/目的:近年来,许多研究者评估了多种病毒作为前列腺癌(男性最常见癌症之一)发生和/或进展潜在因素的作用,包括多瘤病毒(JCV、BKV)和EB病毒。因此,我们旨在评估前列腺癌患者组织中JCPyV DNA的检出频率。方法:我们在49.6%的临床样本中检测到病毒DNA(PCR),其中71.9%为单一EBV感染,28.1%为EBV/JCV共感染。未检测到BKV或单一JCV感染。因此,我们根据风险分级、格里森评分和TNM分期,对EBV单一感染患者与EBV/JCV共感染患者进行了比较。结果:研究结果显示单一EBV感染与EBV/JCV共感染在临床病理特征上存在差异。在单一EBV感染组中,多数患者被归类为中/高风险;而在EBV/JCV共感染组中,多数患者被归类为低风险。结论:与EBV/JCV共感染相比,单一EBV感染患者的前列腺癌分期更晚。此外,单一EBV感染患者的抗EBVCA抗体、抗EBNA抗体水平及EBV载量均高于EBV/JCV共感染患者。在单一EBV感染中,更晚期的肿瘤分期检测到更高的抗体水平。JCV仅是“定植”于前列腺细胞,还是EBV感染的协同因子?基于这些研究,有必要进一步阐明JCV病毒在前列腺癌发生和/或进展中的作用。

 

 

原文链接:

JC Polyomavirus in Prostate Cancer—Friend or Foe?

广告
广告加载中...